Clinical Trial Update: Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating hypofractionated stereotactic radiotherapy in recurrent glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Andre Tsin Chih Chen | Conditions: Recurrent Glioblastoma Multiforme | Phase 2 | Status: COMPLETED